SCHEMBL2818247

SCHEMBL2818247

COc1cc(C)c(S(=O)(=O)N[C@H]2CCCc3ccc(C(=O)O)cc32)c(C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.51
KCNA5 P22460 3/20 0.47
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HTT P42858 1/20 0.43
TAS2R14 Q9NYV8 1/20 0.41
WDR5 P61964 2/20 0.41
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
KDM1A O60341 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MAPT P10636 1/20 0.38
MTNR1A P48039 1/20 0.38
DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2816502 1.00 CYP1A2 (0.51) CYP1A2KCNA5MEN1KMT2APDE4A
SCHEMBL485658 0.94 PDE4A (0.50) CYP1A2KCNA5PDE4APDE4BPDE4C
SCHEMBL2817536 0.93 KCNA5 (0.49) CYP1A2KCNA5MEN1KMT2APDE4A
SCHEMBL484960 0.93 KCNA5 (0.49) CYP1A2KCNA5MEN1KMT2APDE4A
SCHEMBL484959 0.93 KCNA5 (0.49) CYP1A2KCNA5MEN1KMT2APDE4A
SCHEMBL484664 0.86 PDE4A (0.51) KCNA5MEN1KMT2APDE4APDE4B
SCHEMBL2816573 0.82 PDE4A (0.53) CYP1A2KCNA5MEN1KMT2APDE4A
SCHEMBL15235443 0.81 TBXA2R (0.42) CYP1A2ALDH1A1HTTMAPT
SCHEMBL2816618 0.78 CYP3A4 (0.54) CYP1A2ALDH1A1
SCHEMBL2818100 0.78 CYP3A4 (0.54) CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP1A2 3400/4885KCNA5 237/4885MEN1 901/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP1A2 3400/4885KCNA5 237/4885MEN1 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.